Achieving optimal lipid goals in patients with coronary artery disease

American Journal of Cardiology

Volumn 107, Issue 6, 2011, Pages 886-890

  Karalis, Dean G ^a,b   Subramanya, Raghunandan Dudda ^b   Hessen, Scott E ^a,b   Liu, Longjian ^c   Victor, Mark F ^a,b  

^a Cardiology Consultants of Philadelphia   (United States)

^b DREXEL UNIVERSITY COLLEGE OF MEDICINE   (United States)

^c DREXEL UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ATORVASTATIN; BILE ACID SEQUESTRANT; EZETIMIBE; FENOFIBRATE; FENOFIBRIC ACID; FLUINDOSTATIN; GEMFIBROZIL; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LOW DENSITY LIPOPROTEIN CHOLESTEROL; MEVINOLIN; NICOTINIC ACID; OMEGA 3 FATTY ACID; PRAVASTATIN; ROSUVASTATIN; SIMVASTATIN; TRIACYLGLYCEROL;

AGED; ARTICLE; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DRUG MEGADOSE; FEMALE; HIGH RISK PATIENT; HUMAN; LIPID ANALYSIS; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; PRIORITY JOURNAL; REFERENCE VALUE; RISK ASSESSMENT; TRIACYLGLYCEROL BLOOD LEVEL;

AGED; ANTICHOLESTEREMIC AGENTS; AZETIDINES; CHOLESTEROL; CHOLESTEROL, HDL; CHOLESTEROL, LDL; CORONARY DISEASE; FEMALE; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; HYPERCHOLESTEROLEMIA; HYPOLIPIDEMIC AGENTS; LOGISTIC MODELS; MALE; PHYSICIAN'S PRACTICE PATTERNS; SEX FACTORS; TRIGLYCERIDES;

EID: 79952311884     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjcard.2010.11.006     Document Type: Article

References (18)

1. T.A. Pearson, I. Laurora, H. Chu, S. Kafonek The Lipid Treatment Assessment Project (L-TAP) A multicenter survey to evaluate the percentages of dyslipidemic patients receiving lipid-lowering therapy and achieving low-density lipoprotein cholesterol goals Arch Intern Med 160; 2000 459 467 (Pubitemid 30112269)
2. A. Svilaas, K. Risberg, M. Thoresen, and L. Ose Lipid treatment goals achieved in patients treated with statin drugs in Norwegian general practice Am J Cardiol 86 2000 1250 1253
3. J.G. Keevil, M.W. Cullen, R. Gangnon, P.E. McBride, and J.H. Stein Implications of cardiac risk, and low-density lipoprotein cholesterol distributions in the United States for the diagnosis and treatment of dyslipidemia Data from the National Health and Nutrition Survey 1999 to 2002 Circulation 115 2007 1363 1370 (Pubitemid 46648371)
4. H. Ghandehari, S. Kamal-Bahl, and N.D. Wong Prevalence and extent of dyslipidemia and recommended lipid levels in US adults with and without cardiovascular comorbidities: the National Health and Nutrition Examination Survey 2003-2004 Am Heart J 156 2008 112 119
5. M.H. Davidson, K.C. Maki, T.A. Pearson, R.C. Pasternak, P.C. Deedwania, J.M. McKenney, G.C. Fonarow, D.J. Maron, B.J. Ansell, L.T. Clark, and C.M. Ballantyne Results from the National Cholesterol Education (NCEP) Program Evaluation Project Utilizing Novel E-Technology (NEPTUNE) II Survey and implications for treatment under the recent NCEP writing group recommendations Am J Cardiol 96 2005 556 563 (Pubitemid 41132774)
6. A.A. Alsheikh-Ali, J.L. Lin, P. Abourjaily, D. Ahearn, J.T. Kuvin, and R.H. Karas Prevalence of low-density lipoprotein cholesterol in patients with documented coronary heart disease or risk equivalent and controlled low-density lipoprotein cholesterol Am J Cardiol 100 2007 1499 1501 (Pubitemid 350050854)
7. D.D. Waters, C. Brotons, C.W. Chiang, J. Ferrieres, J. Foody, J.W. Jukema, R.D. Santos, J. Verdejo, M. Messig, R. McPherson, K.B. Seung, L. Tarasenko Lipid Treatment Assessment Project 2 Investigators Lipid Treatment Assessment Project 2 A multinational survey to evaluate the proportion of patients achieving low-density lipoprotein cholesterol goals Circulation 120 2009 28 34
8. A.B. Kauffman, K.L. Olson, M.L. Youngblood, E.B. Zadvorny, T. Delate, J.A. Merenich Clinical Pharmacy Cardiac Risk Service Study Group Attainment of low-density lipoprotein goals in coronary artery disease J Clin Lipidol 4 2010 173 180
9. S.M. Grundy, J.I. Cleeman, N.B. Merz, B. Brewer, L.T. Clark, D.B. Hunninghake, R.C. Pasternak, S.C. Smith, N.J. Stone Coordinating Committee of the National Cholesterol Education Program Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines Circulation 110 2004 227 239 (Pubitemid 38924592)
10. Executive summary of the third report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) JAMA 285 2001 2486 2497
11. A.T. Yan, R.T. Yan, M. Tan, D.G. Hackam, K.L. Leblanc, H. Kertland, J.L. Tsang, S. Jaffer, M.L. Kates, L.A. Leiter, D.H. Fitchett, A. Langer, S.G. Goodman Vascular Protection (VP) and Guidelines Oriented Approach to Lipid Lowering (GOALL) Registries Investigators Contemporary management of dyslipidemia in high-risk patients: targets still not met Am J Med 119 2006 676 683 (Pubitemid 44128440)
12. L. Mosca, N.B. Merz, R.S. Blumenthal, M.J. Cziraky, R.P. Fabunmi, C. Sarawate, K.E. Watson, V.J. Willey, and E.J. Stanek Opportunity for intervention to achieve American Heart Association guidelines for optimal lipid levels in high-risk women in a managed care setting Circulation 111 2005 488 493 (Pubitemid 40204434)
13. C.P. Cannon, E. Braunwald, C.H. McCabe, D.J. Rader, J.L. Rouleau, R. Belder, S.V. Joyal, K.A. Hill, M.A. Pfeffer, A.M. Skene Pravastatin or Atorvastatin Evaluation and Infection TherapyThrombolysis In Myocardial Infarction 22 Investigators Intensive versus moderate lipid lowering with statins after acute coronary syndromes N Engl J Med 350 2004 1495 1504 (Pubitemid 38477774)
14. J.C. LaRosa, S.M. Grundy, D.D. Waters, C. Shear, P. Barter, J.C. Fruchart, A.M. Gotto, H. Greten, J.J.P. Kastelein, J. Shepher, N. Wenger Treating to New Targets (TNT) Investigators Intensive lipid lowering with atorvastatin in patients with stable coronary disease N Engl J Med 352 2005 1425 1435 (Pubitemid 40471450)
15. S.E. Nissen, S.J. Nicholls, I. Sipahi, P. Libby, J.S. Raichlen, C.M. Ballantyne, J. Davignon, R. Erbel, J.C. Fruchart, J.C. Tardif, P. Schoenhagen, T. Crowe, V. Cain, K. Wolski, M. Goormastic, E.M. Tuzcu ASTEROID Investigators Effect of very high-intensity statin therapy in regression of coronary atherosclerosis The ASTEROID trial JAMA 295 2006 1556 1565
16. J.R. Crouse, J.S. Raichlen, W.A. Riley, G.W. Evans, M.K. Palmer, D.H. O'Leary, D.E. Grobbee, M.L. Bots METEOR Study Group Effect of rosuvastatin on progression of carotid intima-media thickness in low risk individuals with subclinical atherosclerosis The METEOR trial JAMA 297 2007 1344 1353 (Pubitemid 46513235)
17. H.B. Rubins, S.J. Robins, D. Collins, A. Iranmanesh, T.J. Wilt, D. Mann, M. Mayo-Smith, F.H. Faas, M.B. Elam, G.H. Rutan, J.W. Anderson, M.L. Kashyap, G. Schectman Department of Veterans Affairs HDL Intervention Trial Study Group Distribution of lipids in 8,500 men with coronary artery disease Am J Cardiol 75 1995 1196 1201
18. G.A. Nichols, B.M. Ambegaonkar, V. Sazonov, and J.B. Brown Frequency of obtaining National Cholesterol Education Program Adult Treatment Panel III goals for all major serum lipoproteins after initiation of lipid altering therapy Am J Cardiol 104 2009 1689 1694